Hepatectomy versus transcatheter arterial chemoembolization for resectable BCLC stage A/B hepatocellular carcinoma beyond Milan criteria: A randomized clinical trial.

Front Oncol · 2023 · PMC10010190 · PMID 36923427

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In our study as well, patients with resectable BCLC A stage HCC beyond the Milan criteria who received preoperative TACE achieved a significant survival advantage in OS and PFS at 1, 2, and 3 years post-treatment, although there was a decreasing trend after 3 years.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.